Skip to main content
. Author manuscript; available in PMC: 2022 Dec 20.
Published in final edited form as: J Am Coll Cardiol. 2021 Nov 16;78(20):2004–2012. doi: 10.1016/j.jacc.2021.08.064

Central Illustration. Rationale for Routine In-hospital Initiation of SGLT2i for HFrEF.

Central Illustration.

In-hospital initiation of SGLT2i among eligible patients is supported by multiple patient-centered benefits and a strong safety/tolerability profile well suited for the hospitalized population.